Escaping the trap of allergic rhinitis.

about

Allergic Rhinitis and Chronic Daily Headaches: Is There a Link?Comparison of allergenic extracts from different origins: the value of the FDA's bioequivalent allergy unit (BAU).House dust mite-related respiratory allergies and probiotics: a narrative review.

P2860

Q26768647-4EC5F60D-2D9C-4E47-AF44-52ABF23D72DA Q38842283-131A2CAB-63E8-406F-8717-3D69DFA31E8D Q55481967-8E0440B9-BB93-4D09-8ECD-E71ABE826079

P2860

Escaping the trap of allergic rhinitis.

Item

http://www.wikidata.org/entity/Q39185309

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Escaping the trap of allergic rhinitis.

@en

Escaping the trap of allergic rhinitis.

@nl

type

Item

label

Escaping the trap of allergic rhinitis.

@en

Escaping the trap of allergic rhinitis.

@nl

prefLabel

Escaping the trap of allergic rhinitis.

@en

Escaping the trap of allergic rhinitis.

@nl

P1476

Escaping the trap of allergic rhinitis

@en

P2093

Cristina Quecchia

http://www.w3.org/2001/XMLSchema#string

Ilaria Massaro

http://www.w3.org/2001/XMLSchema#string

Marco Caminati

http://www.w3.org/2001/XMLSchema#string

Oliviero Rossi

http://www.w3.org/2001/XMLSchema#string

P2860

The diagnosis and management of rhinitis: an updated practice parameter

EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy.

Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen).

BSACI guidelines for the management of allergic and non-allergic rhinitis.

Bioavailability and disposition of azelastine and fluticasone propionate when delivered by MP29-02, a novel aqueous nasal spray

Keys to successful management of patients with allergic rhinitis: focus on patient confidence, compliance, and satisfaction.

Allergic rhinitis: the impact of discordant perspectives of patient and physician on treatment decisions.

The voice of the patients: allergic rhinitis is not a trivial disease.

Airway dysfunction in elite athletes--an occupational lung disease?

MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety.

P2888

s12948-015-0023-y

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12948-015-0023-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Enrico Heffler

Giorgio Walter Canonica

Filippo Fassio

P577

2015-08-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280730114

http://www.w3.org/2001/XMLSchema#string

P6179

1012258043

http://www.w3.org/2001/XMLSchema#string

P698

26244040

http://www.w3.org/2001/XMLSchema#string

P932

4524393

http://www.w3.org/2001/XMLSchema#string

Escaping the trap of allergic rhinitis.

about

P2860

P2860

Escaping the trap of allergic rhinitis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698

P932